Home/Pipeline/petadeferitrin

petadeferitrin

Iron overload due to frequent blood transfusions and other iron-related conditions

Not Specified (Clinical development)Active

Key Facts

Indication
Iron overload due to frequent blood transfusions and other iron-related conditions
Phase
Not Specified (Clinical development)
Status
Active
Company

About Pharmacosmos

Pharmacosmos is a long-established, private Danish biotech focused on revolutionizing the prevention and treatment of iron deficiency. Leveraging deep expertise in carbohydrate chemistry and iron metabolism, the company has built a commercial portfolio and is advancing a pipeline targeting iron-related disorders. As a family-owned entity, it emphasizes long-term vision, quality, and sustainable growth, with a significant global commercial footprint in over 40 countries.

View full company profile